Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
112.15    0.00 (0.00%)
Bid:
112.15
Ask:
112.20
Spread: 0.05 (0.045%)
Market Cap: £65.19b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Publication of Final Terms

18 Mar 2026 17:06

RNS Number : 2048X
Lloyds Bank PLC
18 March 2026
 

18 March 2026

 

Lloyds Bank plc

LEI: H7FNTJ4851HG0EXQ1Z70

Publication of Final Terms

The following Final Terms under the €60 billion Global Covered Bond Programme of Lloyds Bank plc are available for viewing:

£1,500,000,000 Series 2026-1 Floating Rate Covered Bonds due March 2029

To view the Final Terms, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/2048X_1-2026-3-18.pdf

The Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

 

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

 

+44 (0) 20 7356 1571

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

 

+44 (0) 7788 352 487

Group Corporate Treasury

Kristofer Middleton

Head of Term Issuance and Capital Structuring

Email: Kristofer.Middleton@lloydsbanking.com

 

+44 (0) 20 7356 1122

 

Head of Debt Investor Relations

 

Niamh O'Connor

Head of Debt Investor Relations

Email: Niamh.O'Connor@lloydsbanking.com

+44 (0) 7350 418011

 

Lloyds Bank plc

Registered Office

25 Gresham Street

London EC2V 7HN

 

Disclaimer - Intended Addressees

Please note that the information contained in this announcement and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and Final Terms are not addressed. Prior to relying on the information contained in this announcement and the Final Terms, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Final Terms.

In particular, this announcement and the Final Terms do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Final Terms are not for distribution in the United States or to U.S. persons (as defined below). The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act) or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTUWRBRNOUOAAR
Date   Source Headline
24th Feb 20235:46 pmRNSTransaction in Own Shares
24th Feb 20235:03 pmRNS2022 Form 20F Filed
23rd Feb 20236:07 pmRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSShare Buyback Programme Commences
22nd Feb 202311:38 amRNSPublication of Suppl.Prospcts
22nd Feb 20237:00 amRNS2022 Annual Report and Accounts
22nd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20235:00 pmRNSDirector/PDMR Shareholding
31st Jan 20234:57 pmRNSTotal Voting Rights
11th Jan 20232:36 pmRNSPublication of Final Terms
11th Jan 20232:15 pmRNSDirector/PDMR Shareholding
3rd Jan 202310:00 amRNSBlock listing Interim Review
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20224:36 pmRNSDirector/PDMR Shareholding
12th Dec 20224:09 pmRNSDirector/PDMR Shareholding
7th Dec 20222:00 pmRNSBlock Listing of Shares
1st Dec 20229:57 amRNSDirector/PDMR Shareholding
30th Nov 20223:31 pmRNSTotal Voting Rights
16th Nov 20224:30 pmRNSDirector/PDMR Shareholding
10th Nov 20223:30 pmRNSDirector/PDMR Shareholding
1st Nov 20229:43 amRNSDirector Declaration
31st Oct 20222:18 pmRNSTotal Voting Rights
27th Oct 202212:07 pmRNSPublication of Supplementary Prospectus
27th Oct 202212:01 pmRNS2022 Q3 Interim Management Statement
27th Oct 20227:00 amRNS2022 Q3 Interim Management Statement
12th Oct 20222:00 pmRNSDirector/PDMR Shareholding
12th Oct 20227:00 amRNSLBG COMPLETES SHARE BUYBACK PROGRAMME
11th Oct 20225:27 pmRNSTransaction in Own Shares
11th Oct 20229:06 amRNSLBG ANNOUNCES RESULTS OF TENDER OFFER
10th Oct 20225:39 pmRNSTransaction in Own Shares
7th Oct 20225:49 pmRNSTransaction in Own Shares
6th Oct 20225:46 pmRNSTransaction in Own Shares
5th Oct 20225:42 pmRNSTransaction in Own Shares
4th Oct 20225:46 pmRNSTransaction in Own Shares
3rd Oct 20225:11 pmRNSTransaction in Own Shares
30th Sep 20225:58 pmRNSTransaction in Own Shares
30th Sep 20224:09 pmRNSTotal Voting Rights
30th Sep 20222:00 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirectorate Change
29th Sep 20225:29 pmRNSTransaction in Own Shares
28th Sep 20225:39 pmRNSTransaction in Own Shares
27th Sep 20225:22 pmRNSTransaction in Own Shares
26th Sep 20225:36 pmRNSTransaction in Own Shares
23rd Sep 20225:40 pmRNSTransaction in Own Shares
23rd Sep 202212:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20229:18 amRNSNotice of Redemption
22nd Sep 20225:43 pmRNSTransaction in Own Shares
22nd Sep 20224:02 pmRNSDirector/PDMR Shareholding
21st Sep 20225:31 pmRNSTransaction in Own Shares
20th Sep 20225:22 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.